MLAB (Mesa Laboratories) Total Payout Ratio: 0.53 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MLAB Mesa Laboratories Inc MLAB
76 GF Score
Price $93.63
GF Value $116.28
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Mesa Laboratories Total Payout Ratio?

Mesa Laboratories MLAB -1.23% 76 Total Payout Ratio is 0.53 as of Jul. 14, 2026. GuruFocus rates MLAB with a GF Score™ of 76/100 and a GF Value™ of $116.28 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Mesa Laboratories's current Total Payout Ratio is 0.53.


Mesa Laboratories Total Payout Ratio Related Terms


Mesa Laboratories Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for Mesa Laboratories's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesa Laboratories Total Payout Ratio Chart

Mesa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.79 3.66 -0.01 -1.76 0.53

Mesa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 0.18 0.36 0.24 -0.21

MLAB vs AERG, USBC, MVIS: Total Payout Ratio Comparison

For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesa Laboratories Total Payout Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Mesa Laboratories's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Mesa Laboratories's Total Payout Ratio falls into.


MLAB
76GF Score
Mesa Laboratories Inc MLAB
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mesa Laboratories Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Mesa Laboratories's Total Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + -3.523) / 6.712
=0.52

Mesa Laboratories's Total Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + -0.884) / -4.136
=-0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Ratio →
What does a Total Payout Ratio of 0.53 mean?
Mesa Laboratories (MLAB) has a Total Payout Ratio of 0.53 as of Jul. 14, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Mesa Laboratories and its competitors.
Is Mesa Laboratories' Total Payout Ratio too high?
Mesa Laboratories' current Total Payout Ratio is 0.53. Overall, Mesa Laboratories has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Total Payout Ratio compare to AERG and USBC?
Mesa Laboratories' Total Payout Ratio of 0.53 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Hardware company?
A good Total Payout Ratio depends on the Hardware industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Mesa Laboratories and its competitors. Mesa Laboratories's current Total Payout Ratio is 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.28, compared to a current price of $93.63 — trading 19.5% below its estimated fair value. The current Total Payout Ratio is 0.53. Mesa Laboratories' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Total Payout Ratio is 0.53 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mesa Laboratories (MLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued. The current stock price of $93.63 is trading 19.5% below its estimated GF Value™ of $116.28. GuruFocus considers Mesa Laboratories to be Modestly Undervalued.

Key valuation signals for MLAB:

  • Total Payout Ratio: 0.53
  • GF Value™: $116.28 vs. price of $93.63 (19.5% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mesa Laboratories Business Description

Address 12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
76GF Score

Get the complete analysis for MLAB

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$93.63
Price
$116.28
GF Value